Market Shifts and Challenges in Pharma

This chapter recaps recent stock market trends, highlighting the record highs of the Dow amid declines in the Nasdaq and S&P. It places particular emphasis on Viking Therapeutics' stock drop due to disappointing trial results for their obesity pill, while analyzing the competitive landscape and potential opportunities for larger firms like Novo Nordisk in the weight loss medication market.